The levels of HBV surface antigen (HBsAg) in transgenic mice ranged from 50 to 200 mg/ml and showed a trend of time-dependent decline.
← all excerpts
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression.
1
—
—
The levels of HBV surface antigen (HBsAg) in transgenic mice ranged from 50 to 200 mg/ml and showed a trend of time-dependent decline.